• Je něco špatně v tomto záznamu ?

European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023

MHM. Oonk, F. Planchamp, P. Baldwin, S. Mahner, MR. Mirza, D. Fischerová, CL. Creutzberg, E. Guillot, G. Garganese, S. Lax, A. Redondo, A. Sturdza, A. Taylor, E. Ulrikh, V. Vandecaveye, A. van der Zee, L. Wölber, D. Zach, GF. Zannoni, I. Zapardiel

. 2023 ; 33 (7) : 1023-1043. [pub] 20230703

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, směrnice pro lékařskou praxi

Perzistentní odkaz   https://www.medvik.cz/link/bmc23016936
E-zdroje Online Plný text

NLK ProQuest Central od 2001-01-01 do Před 6 měsíci
Health & Medicine (ProQuest) od 2001-01-01 do Před 6 měsíci

Odkazy

PubMed 37369376
DOI 10.1136/ijgc-2023-004486
Knihovny.cz E-zdroje

BACKGROUND: As part of its mission to improve the quality of care for women with gynecological cancers across Europe, the European Society of Gynaecological Oncology (ESGO) first published in 2017 evidence-based guidelines for the management of patients with vulvar cancer. OBJECTIVE: To update the ESGO guidelines based on the new evidence addressing the management of vulvar cancer and to cover new topics in order to provide comprehensive guidelines on all relevant issues of diagnosis and treatment of vulvar cancer. METHODS: The ESGO Council nominated an international development group comprised of practicing clinicians who provide care to vulvar cancer patients and have demonstrated leadership through their expertize in clinical care and research, national and international engagement and profile as well as dedication to the topics addressed to serve on the expert panel (18 experts across Europe). To ensure that the statements were evidence-based, new data identified from a systematic search were reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the international development group. Prior to publication, the guidelines were reviewed by 206 international practitioners in cancer care delivery and patient representatives. RESULTS: The updated guidelines cover comprehensively diagnosis and referral, staging, pathology, pre-operative investigations, surgical management (local treatment, groin treatment, sentinel lymph node procedure, reconstructive surgery), (chemo)radiotherapy, systemic treatment, treatment of recurrent disease (vulvar, inguinal, pelvic, and distant recurrences), and follow-up. Management algorithms are also defined.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016936
003      
CZ-PrNML
005      
20231026105444.0
007      
ta
008      
231013s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/ijgc-2023-004486 $2 doi
035    __
$a (PubMed)37369376
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Oonk, Maaike H M $u University Medical Center Groningen, Groningen, The Netherlands m.h.m.oonk@umcg.nl
245    10
$a European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023 / $c MHM. Oonk, F. Planchamp, P. Baldwin, S. Mahner, MR. Mirza, D. Fischerová, CL. Creutzberg, E. Guillot, G. Garganese, S. Lax, A. Redondo, A. Sturdza, A. Taylor, E. Ulrikh, V. Vandecaveye, A. van der Zee, L. Wölber, D. Zach, GF. Zannoni, I. Zapardiel
520    9_
$a BACKGROUND: As part of its mission to improve the quality of care for women with gynecological cancers across Europe, the European Society of Gynaecological Oncology (ESGO) first published in 2017 evidence-based guidelines for the management of patients with vulvar cancer. OBJECTIVE: To update the ESGO guidelines based on the new evidence addressing the management of vulvar cancer and to cover new topics in order to provide comprehensive guidelines on all relevant issues of diagnosis and treatment of vulvar cancer. METHODS: The ESGO Council nominated an international development group comprised of practicing clinicians who provide care to vulvar cancer patients and have demonstrated leadership through their expertize in clinical care and research, national and international engagement and profile as well as dedication to the topics addressed to serve on the expert panel (18 experts across Europe). To ensure that the statements were evidence-based, new data identified from a systematic search were reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the international development group. Prior to publication, the guidelines were reviewed by 206 international practitioners in cancer care delivery and patient representatives. RESULTS: The updated guidelines cover comprehensively diagnosis and referral, staging, pathology, pre-operative investigations, surgical management (local treatment, groin treatment, sentinel lymph node procedure, reconstructive surgery), (chemo)radiotherapy, systemic treatment, treatment of recurrent disease (vulvar, inguinal, pelvic, and distant recurrences), and follow-up. Management algorithms are also defined.
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    12
$a gynekologie $x metody $7 D006176
650    12
$a zákroky plastické chirurgie $7 D019651
650    12
$a nádory vulvy $x diagnóza $x terapie $x patologie $7 D014846
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a směrnice pro lékařskou praxi $7 D017065
700    1_
$a Planchamp, François $u Institut Bergonie, Bordeaux, France $1 https://orcid.org/0000000287090410
700    1_
$a Baldwin, Peter $u Addenbrooke's Hospital, Cambridge, UK
700    1_
$a Mahner, Sven $u University Hospital, Ludwig Maximilians University Munich, Munich, Germany
700    1_
$a Mirza, Mansoor Raza $u Rigshospitalet; Copenhagen University Hospital, Copenhagen, Denmark
700    1_
$a Fischerová, Daniela $u Charles University First Faculty of Medicine, Prague, Czech Republic $u General University Hospital in Prague, Prague, Czech Republic $1 https://orcid.org/0000000272243218 $7 xx0074804
700    1_
$a Creutzberg, Carien L $u Leiden University Medical Center, Leiden, The Netherlands
700    1_
$a Guillot, Eugénie $u Institut Curie, Paris, France
700    1_
$a Garganese, Giorgia $u Catholic University of the Sacred Heart, Rome, Italy $u Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
700    1_
$a Lax, Sigurd $u Hospital Graz II, Graz, Austria $u Johannes Kepler Universitat Linz, Linz, Austria
700    1_
$a Redondo, Andres $u La Paz University Hospital, Madrid, Spain
700    1_
$a Sturdza, Alina $u University Hospital Vienna, Vienna, Austria
700    1_
$a Taylor, Alexandra $u Royal Marsden NHS Foundation Trust, London, UK $1 https://orcid.org/0000000181005388
700    1_
$a Ulrikh, Elena $u Almazov National Medical Research Center, Saint Petersburg, Russian Federation $1 https://orcid.org/0000000227018812
700    1_
$a Vandecaveye, Vincent $u KU Leuven University Hospitals Leuven, Leuven, Belgium $1 https://orcid.org/0000000208003279
700    1_
$a van der Zee, Ate $u University Medical Center Groningen, Groningen, The Netherlands
700    1_
$a Wölber, Linn $u University Medical Center Hamburg-Eppendorf, Hamburg, Germany
700    1_
$a Zach, Diana $u Karolinska University Hospital, Stockholm, Sweden $u Karolinska Institutet Eugeniavägen, Stockholm, Sweden
700    1_
$a Zannoni, Gian Franco $u Catholic University of the Sacred Heart, Rome, Italy $u Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy $1 https://orcid.org/0000000244737560
700    1_
$a Zapardiel, Ignacio $u La Paz University Hospital, Madrid, Spain $1 https://orcid.org/0000000291757767
773    0_
$w MED00009896 $t International journal of gynecological cancer : official journal of the International Gynecological Cancer Society $x 1525-1438 $g Roč. 33, č. 7 (2023), s. 1023-1043
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37369376 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026105439 $b ABA008
999    __
$a ok $b bmc $g 2000454 $s 1203298
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 33 $c 7 $d 1023-1043 $e 20230703 $i 1525-1438 $m International journal of gynecological cancer $n Int J Gynecol Cancer $x MED00009896
LZP    __
$a Pubmed-20231013

Najít záznam

Citační ukazatele

Možnosti archivace